Tipranks Press Release.
Iovance stock sank after phase 2 Amtagvi lung cancer data. Read more here.
Detailed price information for Merck & Company (MRK-N) from The Globe and Mail including charting and trades.
2026-10-29. The following slide deck was published by Iovance Biotherapeutics, Inc.
Iovance stock crashed Thursday, undercutting its 50-day line, on new durability questions for its lung cancer treatment.
24.6% Objective Response Rate (ORR) in 69 Patients with Non-Squamous mNSCLC, Consistent with Previously Reported Results IOV-LUN-202 Cohorts 1 and 2 Are Completing Enrollment and Support a Planned Supplemental Biologics License Application (sBLA) for Lifileucel in Non-Squamous mNSCLC in 2027 KRAS Wild-Type Subgroup Achieved 43.3% ORR Versus 11.4% in KRAS-Mutant Disease and Novel Biomarker-Enriched Subgroup Achieved 59.1% ORR POSITILITY, a First-In-Class Biomarker-Enriched Study with Registration
Phase 2 data show Amtagvi plus Keytruda delivered strong frontline advanced melanoma responses. Read more here.
Iovance Advances TIL Cell Therapy into a New Chapter in Solid Tumor Treatment Two Oral Presentations to Showcase Deep, Durable Responses with TIL Cell Therapy in Frontline Melanoma and Previously Treated Soft Tissue Sarcomas PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) cell therapies for patients with cancer, wi
Iovance Biotherapeutics (NASDAQ:IOVA) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you
Three healthcare stocks—Quantum-Si, Kodiak Sciences and Iovance—show overbought RSI readings above 80, warning momentum-focused investors.
Iovance raised 2026 revenue guidance as Amtagvi adoption accelerates with broader access, physician awareness, and faster manufacturing. Learn more about IOVA stock here.
This is the newest page. Registered accounts read further back.